11583202

Source:http://linkedlifedata.com/resource/pubmed/id/11583202

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019829, umls-concept:C0079731, umls-concept:C0393022, umls-concept:C0544452, umls-concept:C1510411
pubmed:issue	8
pubmed:dateCreated	2001-10-3
pubmed:abstractText	We demonstrate the usefulness of immunotherapy with the CD20 antibody Rituximab in a case of transformation of Hodgkin's disease (HD) to high-grade non-Hodgkin's lymphoma (NHL).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal..., http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Bleomycin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Procarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0923-7534
pubmed:author	pubmed-author:EbsenMM, pubmed-author:KirchnerE MEM, pubmed-author:KirchnerJJ, pubmed-author:TheegartenDD, pubmed-author:VoigtmannRR
pubmed:issnType	Print
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1169-71
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:11583202-Antibodies, Monoclonal, pubmed-meshheading:11583202-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:11583202-Antineoplastic Agents, pubmed-meshheading:11583202-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11583202-Bleomycin, pubmed-meshheading:11583202-Cell Transformation, Neoplastic, pubmed-meshheading:11583202-Cyclophosphamide, pubmed-meshheading:11583202-Dacarbazine, pubmed-meshheading:11583202-Doxorubicin, pubmed-meshheading:11583202-Drug Resistance, Neoplasm, pubmed-meshheading:11583202-Female, pubmed-meshheading:11583202-Hodgkin Disease, pubmed-meshheading:11583202-Humans, pubmed-meshheading:11583202-Lymphoma, B-Cell, pubmed-meshheading:11583202-Lymphoma, Non-Hodgkin, pubmed-meshheading:11583202-Middle Aged, pubmed-meshheading:11583202-Neoplasm Staging, pubmed-meshheading:11583202-Neoplasms, Second Primary, pubmed-meshheading:11583202-Prednisone, pubmed-meshheading:11583202-Procarbazine, pubmed-meshheading:11583202-Remission Induction, pubmed-meshheading:11583202-Vinblastine, pubmed-meshheading:11583202-Vincristine
pubmed:year	2001
pubmed:articleTitle	Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
pubmed:affiliation	Abteilung für Hämatologie/Onkologie, Katholisches Marienhospital Herne, Universitätsklinik, Germany.
pubmed:publicationType	Journal Article, Case Reports